A detailed history of Centiva Capital, LP transactions in Personalis, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 50,527 shares of PSNL stock, worth $251,119. This represents 0.01% of its overall portfolio holdings.

Number of Shares
50,527
Previous 40,372 25.15%
Holding current value
$251,119
Previous $233,000 24.03%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$3.51 - $6.64 $35,644 - $67,429
10,155 Added 25.15%
50,527 $177,000
Q4 2024

Feb 14, 2025

SELL
$3.38 - $6.26 $102,217 - $189,314
-30,242 Reduced 42.83%
40,372 $233,000
Q3 2024

Nov 14, 2024

BUY
$1.19 - $6.34 $84,030 - $447,692
70,614 New
70,614 $379,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $228M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.